Our term sheet we have with the Manitoba government, and what was proposed across the board in Canada, was $18 Canadian a dose. I'm not ashamed to say that Providence is making a fairly reasonable profit at that price. If there was an opportunity to do something and improve on that pricing, we certainly would look at it.
Once we have the full supply chain integrated into Canada, which we are in the process of doing, we will be able to reduce those prices further. Right now we still currently rely for 2021 on an international supply chain, and we're looking to reduce that reliance by 2022—